Literature DB >> 24232870

Advanced imaging of cardiac sarcoidosis.

Imke Schatka1, Frank M Bengel.   

Abstract

Sarcoidosis is a systemic granulomatous disease of unknown etiology. Cardiac involvement may occur, leading to an adverse outcome. Although early treatment to improve morbidity and mortality is desirable, sensitive and accurate detection of cardiac sarcoidosis remains a challenge. Accordingly, interest in the use of advanced imaging such as cardiac MR and PET with (18)F-FDG is increasing in order to refine the clinical workup. Although the field is still facing challenges and uncertainties, this article presents a summary of clinical background and the current state of diagnostic modalities and treatment of cardiac sarcoidosis.

Entities:  

Keywords:  [18F]-deoxyglucose; cardiac sarcoidosis; inflammation; magnetic resonance imaging; positron emission tomography

Mesh:

Substances:

Year:  2013        PMID: 24232870     DOI: 10.2967/jnumed.112.115121

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  38 in total

1.  Molecular cardiovascular imaging is ready for prime time: almost there.

Authors:  Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

2.  Ischaemic vs non-ischaemic dilated cardiomyopathy: The value of nuclear cardiology techniques.

Authors:  Federico Caobelli; Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2015-07-08       Impact factor: 5.952

Review 3.  Imaging of Sarcoidosis.

Authors:  Mario Silva; Hilario Nunes; Dominique Valeyre; Nicola Sverzellati
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

4.  Multimodality imaging in the diagnosis and management of cardiac sarcoidosis.

Authors:  Shant J Manoushagian; Vladimir Lakhter; Pravin V Patil
Journal:  J Nucl Cardiol       Date:  2016-11-11       Impact factor: 5.952

5.  Role of multimodality imaging including Thallium-201 myocardial perfusion imaging in the diagnosis and monitoring of treatment response in cardiac sarcoidosis.

Authors:  Devaki Shilpa Surasi; Padma Priya Manapragada; Steven G Lloyd; Pradeep Bhambhvani
Journal:  J Nucl Cardiol       Date:  2014-02-04       Impact factor: 5.952

6.  Do we need PET?

Authors:  Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2014-06       Impact factor: 5.952

7.  ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.

Authors:  Vasken Dilsizian; Stephen L Bacharach; Rob S Beanlands; Steven R Bergmann; Dominique Delbeke; Sharmila Dorbala; Robert J Gropler; Juhani Knuuti; Heinrich R Schelbert; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2016-07-08       Impact factor: 5.952

Review 8.  Cardiovascular PET/MR imaging: Quo Vadis?

Authors:  Thomas Hellmut Schindler
Journal:  J Nucl Cardiol       Date:  2016-09-22       Impact factor: 5.952

9.  The logic and challenges of imaging sarcoidosis with whole body FDG PET.

Authors:  Roberto C Valentin; Pradeep Bhambhvani
Journal:  J Nucl Cardiol       Date:  2017-08-17       Impact factor: 5.952

Review 10.  Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.

Authors:  Patrick Krumm; Stefanie Mangold; Sergios Gatidis; Konstantin Nikolaou; Felix Nensa; Fabian Bamberg; Christian la Fougère
Journal:  Jpn J Radiol       Date:  2018-03-10       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.